110 related articles for article (PubMed ID: 3739882)
1. Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease.
Nitenberg A; Foult JM; Kahan A; Perennec J; Devaux JY; Menkes CJ; Amor B
Am Heart J; 1986 Aug; 112(2):309-15. PubMed ID: 3739882
[TBL] [Abstract][Full Text] [Related]
2. Decreased coronary reserve in primary scleroderma myocardial disease.
Kahan A; Nitenberg A; Foult JM; Amor B; Menkes CJ; Devaux JY; Blanchet F; Perennec J; Lutfalla G; Roucayrol JC
Arthritis Rheum; 1985 Jun; 28(6):637-46. PubMed ID: 4004974
[TBL] [Abstract][Full Text] [Related]
3. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries.
Nitenberg A; Foult JM; Antony I; Blanchet F; Rahali M
J Am Coll Cardiol; 1988 Mar; 11(3):478-86. PubMed ID: 3278034
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
[TBL] [Abstract][Full Text] [Related]
5. Regional myocardial blood flow in man during dipyridamole coronary vasodilation.
Sorensen SG; Groves BM; Horwitz LD; Chaudhuri TK
Chest; 1985 Jun; 87(6):735-9. PubMed ID: 3996059
[TBL] [Abstract][Full Text] [Related]
6. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy.
Nitenberg A; Foult JM; Blanchet F; Zouioueche S
Am J Cardiol; 1985 Mar; 55(6):748-54. PubMed ID: 3976520
[TBL] [Abstract][Full Text] [Related]
7. Abnormal coronary vasomotion during exercise in patients with normal coronary arteries and reduced coronary flow reserve.
Bortone AS; Hess OM; Eberli FR; Nonogi H; Marolf AP; Grimm J; Krayenbuehl HP
Circulation; 1989 Mar; 79(3):516-27. PubMed ID: 2492909
[TBL] [Abstract][Full Text] [Related]
8. Maximal coronary vasodilator capacity of orthotopic heart transplants in patients with and without rejection.
Nitenberg A; Tavolaro O; Loisance D; Foult JM; Hittinger L; Aptecar E; Cachera JP
Am J Cardiol; 1989 Sep; 64(8):513-8. PubMed ID: 2672759
[TBL] [Abstract][Full Text] [Related]
9. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
Cannon RO; Schenke WH; Leon MB; Rosing DR; Urqhart J; Epstein SE
Circulation; 1987 Jan; 75(1):163-74. PubMed ID: 3791602
[TBL] [Abstract][Full Text] [Related]
10. [Myocardial microvascularization in scleroderma].
Kahan A; Devaux JY; Weber S; Nitenberg A; Amor B; Menkes CJ; Guerin F; Degeorges M
Arch Mal Coeur Vaiss; 1988 Apr; 81(4):495-500. PubMed ID: 3136710
[TBL] [Abstract][Full Text] [Related]
11. Effect of cold stress on coronary sinus blood flow in patients with scleroderma.
Colfer HT; Das SK; Dabich L; Randall OS; Pitt B
J Assoc Acad Minor Phys; 1993; 4(2):62-5. PubMed ID: 8490289
[TBL] [Abstract][Full Text] [Related]
12. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease.
Uren NG; Marraccini P; Gistri R; de Silva R; Camici PG
J Am Coll Cardiol; 1993 Sep; 22(3):650-8. PubMed ID: 8354794
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal coronary vasomotility in subjects with normal coronary arteries and reduced reserve of coronary flow].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Musci S; Sebastiani M; Rizzon P; Chiddo A
Cardiologia; 1989 Jan; 34(1):33-46. PubMed ID: 2720712
[TBL] [Abstract][Full Text] [Related]
14. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.
Follansbee WP; Curtiss EI; Medsger TA; Steen VD; Uretsky BF; Owens GR; Rodnan GP
N Engl J Med; 1984 Jan; 310(3):142-8. PubMed ID: 6690931
[TBL] [Abstract][Full Text] [Related]
15. Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy.
Shimamatsu M; Toshima H
Jpn Heart J; 1987 May; 28(3):387-401. PubMed ID: 3626022
[TBL] [Abstract][Full Text] [Related]
16. Transient myocardial dysfunction during pharmacologic vasodilation as an index of reduced coronary reserve: a coronary hemodynamic and echocardiographic study.
Picano E; Simonetti I; Masini M; Marzilli M; Lattanzi F; Distante A; De Nes M; L'Abbate A
J Am Coll Cardiol; 1986 Jul; 8(1):84-90. PubMed ID: 3711535
[TBL] [Abstract][Full Text] [Related]
17. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients.
Opherk D; Schwarz F; Mall G; Manthey J; Baller D; Kübler W
Am J Cardiol; 1983 Jun; 51(10):1657-62. PubMed ID: 6858872
[TBL] [Abstract][Full Text] [Related]
18. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole, and coronary artery occlusion.
Melin JA; Becker LC
J Nucl Med; 1986 May; 27(5):641-52. PubMed ID: 3012029
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT.
Chin BB; Moshin J; Bouchard M; Berlin JA; Araujo LI; Alavi A
J Nucl Med; 1996 May; 37(5):723-9. PubMed ID: 8965134
[TBL] [Abstract][Full Text] [Related]
20. Influence of age and hemodynamics on myocardial blood flow and flow reserve.
Czernin J; Müller P; Chan S; Brunken RC; Porenta G; Krivokapich J; Chen K; Chan A; Phelps ME; Schelbert HR
Circulation; 1993 Jul; 88(1):62-9. PubMed ID: 8319357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
